138 related articles for article (PubMed ID: 31042669)
1. Effects of interleukin-1 antagonism on cortisol levels in individuals with obesity: a randomized clinical trial.
Ebrahimi F; Urwyler SA; Schuetz P; Mueller B; Bernasconi L; Neyer P; Donath MY; Christ-Crain M
Endocr Connect; 2019 Jun; 8(6):701-708. PubMed ID: 31042669
[TBL] [Abstract][Full Text] [Related]
2. IL-1 Antagonism in Men With Metabolic Syndrome and Low Testosterone: A Randomized Clinical Trial.
Ebrahimi F; Urwyler SA; Straumann S; Doerpfeld S; Bernasconi L; Neyer P; Schuetz P; Mueller B; Donath MY; Christ-Crain M
J Clin Endocrinol Metab; 2018 Sep; 103(9):3466-3476. PubMed ID: 29939279
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 Antagonism Decreases Cortisol Levels in Obese Individuals.
Urwyler SA; Schuetz P; Ebrahimi F; Donath MY; Christ-Crain M
J Clin Endocrinol Metab; 2017 May; 102(5):1712-1718. PubMed ID: 28324042
[TBL] [Abstract][Full Text] [Related]
4. Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome.
Ebrahimi F; Urwyler SA; Betz MJ; Christ ER; Schuetz P; Mueller B; Donath MY; Christ-Crain M
Sci Rep; 2021 Apr; 11(1):7911. PubMed ID: 33846498
[TBL] [Abstract][Full Text] [Related]
5. IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1-7]) and Decreases Blood Pressure in Obese Individuals.
Urwyler SA; Ebrahimi F; Burkard T; Schuetz P; Poglitsch M; Mueller B; Donath MY; Christ-Crain M
Hypertension; 2020 Jun; 75(6):1455-1463. PubMed ID: 32275191
[TBL] [Abstract][Full Text] [Related]
6. IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.
Van Tassell BW; Trankle CR; Canada JM; Carbone S; Buckley L; Kadariya D; Del Buono MG; Billingsley H; Wohlford G; Viscusi M; Oddi-Erdle C; Abouzaki NA; Dixon D; Biondi-Zoccai G; Arena R; Abbate A
Circ Heart Fail; 2018 Aug; 11(8):e005036. PubMed ID: 30354558
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).
Van Tassell BW; Canada J; Carbone S; Trankle C; Buckley L; Oddi Erdle C; Abouzaki NA; Dixon D; Kadariya D; Christopher S; Schatz A; Regan J; Viscusi M; Del Buono M; Melchior R; Mankad P; Lu J; Sculthorpe R; Biondi-Zoccai G; Lesnefsky E; Arena R; Abbate A
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29141858
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis: extension phase of a randomized, double-blind, placebo-controlled trial.
Nuki G; Bresnihan B; Bear MB; McCabe D;
Arthritis Rheum; 2002 Nov; 46(11):2838-46. PubMed ID: 12428223
[TBL] [Abstract][Full Text] [Related]
9. Muscle-Derived IL-6 Is Not Regulated by IL-1 during Exercise. A Double Blind, Placebo-Controlled, Randomized Crossover Study.
Nordmann TM; Seelig E; Timper K; Cordes M; Coslovsky M; Hanssen H; Schmidt-Trucksäss A; Donath MY
PLoS One; 2015; 10(10):e0139662. PubMed ID: 26448147
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial.
Tzanetakou V; Kanni T; Giatrakou S; Katoulis A; Papadavid E; Netea MG; Dinarello CA; van der Meer JWM; Rigopoulos D; Giamarellos-Bourboulis EJ
JAMA Dermatol; 2016 Jan; 152(1):52-59. PubMed ID: 26579854
[TBL] [Abstract][Full Text] [Related]
11. Cytokine Inhibition in Patients With Chronic Fatigue Syndrome: A Randomized Trial.
Roerink ME; Bredie SJH; Heijnen M; Dinarello CA; Knoop H; Van der Meer JWM
Ann Intern Med; 2017 Apr; 166(8):557-564. PubMed ID: 28265678
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 given to asymptomatic HIV-infected individuals leads to an exaggerated response of the pituitary gland to the action of CRH.
Witzke O; Winterhagen T; Kribben A; Philipp T; Mann K; Reinhardt W
Clin Endocrinol (Oxf); 2003 Jul; 59(1):104-9. PubMed ID: 12807511
[TBL] [Abstract][Full Text] [Related]
13. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial.
Brucato A; Imazio M; Gattorno M; Lazaros G; Maestroni S; Carraro M; Finetti M; Cumetti D; Carobbio A; Ruperto N; Marcolongo R; Lorini M; Rimini A; Valenti A; Erre GL; Sormani MP; Belli R; Gaita F; Martini A
JAMA; 2016 Nov; 316(18):1906-1912. PubMed ID: 27825009
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
Arvat E; Maccagno B; Giordano R; Pellegrino M; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2001 Jul; 86(7):3176-81. PubMed ID: 11443185
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).
Abbate A; Kontos MC; Grizzard JD; Biondi-Zoccai GG; Van Tassell BW; Robati R; Roach LM; Arena RA; Roberts CS; Varma A; Gelwix CC; Salloum FN; Hastillo A; Dinarello CA; Vetrovec GW;
Am J Cardiol; 2010 May; 105(10):1371-1377.e1. PubMed ID: 20451681
[TBL] [Abstract][Full Text] [Related]
16. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
[TBL] [Abstract][Full Text] [Related]
17. Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial.
Amparo F; Dastjerdi MH; Okanobo A; Ferrari G; Smaga L; Hamrah P; Jurkunas U; Schaumberg DA; Dana R
JAMA Ophthalmol; 2013 Jun; 131(6):715-723. PubMed ID: 23599118
[TBL] [Abstract][Full Text] [Related]
18. IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial.
Ridker PM; Devalaraja M; Baeres FMM; Engelmann MDM; Hovingh GK; Ivkovic M; Lo L; Kling D; Pergola P; Raj D; Libby P; Davidson M;
Lancet; 2021 May; 397(10289):2060-2069. PubMed ID: 34015342
[TBL] [Abstract][Full Text] [Related]
19. A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate.
Cohen SB; Moreland LW; Cush JJ; Greenwald MW; Block S; Shergy WJ; Hanrahan PS; Kraishi MM; Patel A; Sun G; Bear MB;
Ann Rheum Dis; 2004 Sep; 63(9):1062-8. PubMed ID: 15082469
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
